(redirected from fluorine-18 fluorodeoxyglucose)


A radio-fluorine derivative used to trace metabolic activity or detect malignant tissue; commonly used as the agent in positron emission tomography (PET).


, fluorine-18 fluorodeoxyglucose (floo?(o-)ro-de-ok?se-gloo'kos?) (floor'en?de-ok?se-gloo'kos?, floo'o-ren?de-ok?se-gloo'kos?),

FDG; fluorine-18 FDG.

A fluorinated radiographically visible glucose molecule that serves as a contrast agent. Synonym: fludeoxyglucose
References in periodicals archive ?
PEM uses a pair of dedicated gamma radiation detectors placed above and below the breast and mild breast compression to detect coincident gamma rays after administration of fluorine-18 fluorodeoxyglucose ([sup.
Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography.
Positron emission tomography/computed tomography (PET/CT) with fluorine-18 fluorodeoxyglucose (F-18 FDG) is well established as a valuable tool in the staging and restaging of Hodgkin's and certain non-Hodgkin's lymphomas, including the assessment of response to treatment.
Fluorine-18 fluorodeoxyglucose (FDG)-PET scan if no evidence of distant metastatic disease on CT.
The current standard in cancer molecular imaging is fluorine-18 FluoroDeoxyGlucose (18F-FDG) imaged using a Positron Emission Tomography (PET) camera, which are rare.
NEW ORLEANS--Refinements to fluorine-18 fluorodeoxyglucose PET imaging are improving the technique's utility in diagnosis and management of cancer.
Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study.
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry.
The study, published in the December 2003 issue of the journal Technology in Cancer Research and Treatment (TCRT), is entitled, "DYNAMIC INFRARED IMAGE OF NEWLY DIAGNOSED MALIGNANT LYMPHOMA COMPARED WITH GALLIUM-67 AND FLUORINE-18 FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET).
Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?